Literature DB >> 16306629

Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.

E Rodríguez-Iñigo1, J Bartolomé, N Ortiz-Movilla, C Platero, J M López-Alcorocho, M Pardo, I Castillo, V Carreño.   

Abstract

In this work, we have shown that hepatitis C virus (HCV) and hepatitis B virus (HBV) can coexist in the same hepatocyte using double fluorescent in situ hybridization in liver biopsy samples from patients with chronic HCV infection with occult HBV infection. Digital image analysis of hybridization signals showed that the HBV DNA levels in coinfected hepatocytes were lower than those in cells infected only with HBV. This finding supports the hypothesis of inhibition of HBV replication by HCV. Furthermore, HCV RNA levels were lower in coinfected cells than in cells infected only with HCV, suggesting that HBV may also inhibit HCV replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306629      PMCID: PMC1316020          DOI: 10.1128/JVI.79.24.15578-15581.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

Review 1.  Replication of hepatitis C virus.

Authors:  R Bartenschlager; V Lohmann
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

Review 2.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein.

Authors:  Shiow-Yi Chen; Chih-Fei Kao; Chun-Ming Chen; Chwen-Ming Shih; Ming-Jen Hsu; Chi-Hong Chao; Shao-Hung Wang; Li-Ru You; Yan-Hwa Wu Lee
Journal:  J Biol Chem       Date:  2002-10-24       Impact factor: 5.157

4.  Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance.

Authors:  R Fukuda; N Ishimura; M Niigaki; S Hamamoto; S Satoh; S Tanaka; Y Kushiyama; Y Uchida; S Ihihara; S Akagi; M Watanabe; Y Kinoshita
Journal:  J Med Virol       Date:  1999-07       Impact factor: 2.327

5.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.

Authors:  D S Chen; G C Kuo; J L Sung; M Y Lai; J C Sheu; P J Chen; P M Yang; H M Hsu; M H Chang; C J Chen
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

6.  Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.

Authors:  Elena Rodríguez-Iñigo; Luisa Mariscal; Javier Bartolomé; Inmaculada Castillo; Cristina Navacerrada; Nuria Ortiz-Movilla; Margarita Pardo; Vicente Carreño
Journal:  J Med Virol       Date:  2003-08       Impact factor: 2.327

7.  Hepatitis C virus NS2 protein inhibits gene expression from different cellular and viral promoters in hepatic and nonhepatic cell lines.

Authors:  Franz Ludwig Dumoulin; Annette von dem Bussche; Jisu Li; Leila Khamzina; Jack R Wands; Tilman Sauerbruch; Ulrich Spengler
Journal:  Virology       Date:  2003-01-20       Impact factor: 3.616

8.  Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein.

Authors:  Christian G Schüttler; Nicola Fiedler; Katja Schmidt; Reinald Repp; Wolfram H Gerlich; Stephan Schaefer
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

9.  HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.

Authors:  Evangelista Sagnelli; Nicola Coppola; Vincenzo Messina; Domenico Di Caprio; Cecilia Marrocco; Anna Marotta; Mirella Onofrio; Carlo Scolastico; Pietro Filippini
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 10.  Recent advances in the molecular biology of hepatitis C virus.

Authors:  S Rosenberg
Journal:  J Mol Biol       Date:  2001-10-26       Impact factor: 5.469

View more
  16 in total

Review 1.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

2.  Editorial Commentary: Another Call to Cure Hepatitis B.

Authors:  Ashwin Balagopal; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

Review 3.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 4.  Hepatitis B virus and hepatitis C virus dual infection.

Authors:  Gaia Caccamo; Francesca Saffioti; Giovanni Raimondo
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

5.  [Spontaneous remission of HCV infection after autologous stem cell transplantation in a 58-year-old man].

Authors:  L Reinhardt; H Eiffert; G Wulf; P Ströbel; S C B Bremer; A Amanzada; V Ellenrieder; A Neesse
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

Review 6.  Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).

Authors:  Jason T Blackard; Kenneth E Sherman
Journal:  Rev Med Virol       Date:  2018-05-15       Impact factor: 6.989

7.  Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection.

Authors:  Shuhui Liu; Kaitao Zhao; Xi Su; Xiaoxiao Gao; Yongxuan Yao; Ranran Kong; Yun Wang; Chunchen Wu; Mengji Lu; Xinwen Chen; Rongjuan Pei
Journal:  Virol Sin       Date:  2022-05-03       Impact factor: 6.947

8.  Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in southwest of iran.

Authors:  Seyed Jalal Hashemi; Eskandar Hajiani; Abdolrahim Masjedizadeh; Manoochehr Makvandi; Ali Akbar Shayesteh; Seyed Pejman Alavinejad; Ahmad Kadkhodaei; Heshmatollah Shahbazian; Farzad Jasemi; Mohamad Karimi
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

Review 9.  Occult HBV infection: a faceless enemy in liver cancer development.

Authors:  Jaime Morales-Romero; Gustavo Vargas; Rebeca García-Román
Journal:  Viruses       Date:  2014-04-08       Impact factor: 5.048

10.  Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway.

Authors:  Haitao Guo; Tianlun Zhou; Dong Jiang; Andrea Cuconati; Guang-Hui Xiao; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.